Extracorporeal shockwave lithotripsy versus ureteroscopy for distal ureteric calculi: efficacy and patient satisfaction

Authors:
  • Zahid Ullah khan , Specialist Registrar, Institute of Kidney diseases Hayatabad Peshawar
  • Irfan Ullah khan , Assistant Professor of Urology, Northwest General Hospital and Research Center Peshawar
  • Hamza khan , Resident Urologist, Urology Department, Lady Reading Hospital Peshawar KPK
  • Israr Ali Khan , Assistant professor, Urology Department Khalifa Gul Nawaz Teaching Hospital, MTI Bannu
  • Suneeta Kumaree , Oriana Blu medical center, UAE
  • Jamil Ahmad , Department of Laboratory, Oriana hospital and Clinic, UAE

Article Information:

Published:December 4, 2025
Article Type:Original Research
Pages:4501 - 4507
Received:August 12, 2025
Accepted:October 20, 2025

Abstract:

Introduction: Distal ureteric calculi are a frequent cause of acute urological symptoms. Extracorporeal shockwave lithotripsy (ESWL) and ureteroscopy (URS) are the main treatment options, yet differences in efficacy and patient outcomes remain clinically relevant. Objective: To compare the efficacy, complications, postoperative pain, and patient satisfaction between ESWL and URS. Methodology: This comparative prospective study was conducted at Institute of Kidney diseases Hayatabad Peshawar for a period of six months from January 2025 to June 2025. A total of 106 patients with single distal ureteric stones (5–15 mm) were enrolled and divided into ESWL (n=53) and URS (n=53) groups. Outcomes included stone-free rate (SFR), complications, pain scores, and satisfaction. Statistical tests applied were Chi-square, independent t-tests, and multivariate logistic regression. Results: The SFR was significantly higher in the URS group 48 (90.6%) than in the ESWL group 36 (67.9%) (p = 0.0035). Complications were more frequent in ESWL 15 (28.3%) compared with URS 7 (13.2%) (p = 0.046). Pain scores were lower in ESWL (4.9 ± 1.6) than in URS (5.8 ± 1.9; p = 0.008). Satisfaction was higher in URS (4.3 ± 0.7) than in ESWL (3.6 ± 0.8; p < 0.001). URS remained the strongest predictor of stone clearance on multivariate analysis (OR = 4.21, p = 0.005). Conclusion: URS provided higher stone clearance and satisfaction than ESWL, supporting its use as the more effective treatment for distal ureteric calculi, while ESWL offers a non-invasive alternative with lower postoperative pain.

Keywords:

Ureteroscopy Lithotripsy Extracorporeal Shock Wave Ureteral Calculi Patient Satisfaction Urolithiasis.

Article :

INTRODUCTION:

Urinary stone disease is a widespread urological issue, and distal ureteric calculi often develop renal colic, hematuria, and hydronephrosis [1]. Early and good intervention is very essential to avoid complications and save renal performance [2]. Open surgery has been nearly eliminated by minimally invasive surgery, such as Extracorporeal Shockwave Lithotripsy (ESWL) and Ureteroscopy (URS) which provide same-day recovery and reduced patient discomfort [3]. ESWL is not invasive and can be done on an inpatient basis in many instances and does not need general anesthesia although it might be necessary to have several procedures to ensure the stones have been cleared [4].

 

URS, by offering progress in semi-rigid and flexible scopes and laser lithotripsy offers greater clearance of the stones immediately and permits direct extraction of fragments [5]. It has been demonstrated that in case of distal ureteral stones, URS has better stone free rates over ESWL and less retreatment [6]. But ESWL can have some benefits in terms of hospital stay and less invasive procedure in terms of invasiveness [7]. Clinical outcome is not the sole contributor to patient satisfaction, but the treatment experience, pain, recovery time, and repeat procedure requirement are also included [8].

 

The choice of treatment depends on various factors which may include stone size, composition, anatomical position and co-morbidity of the patient [9]. Also, the availability of resources, expertise of surgeons, and cost-efficiency are significant factors especially in the third world [10]. Knowledge of these factors and efficacy and patient satisfaction is critical to streamline treatment plans [11]. According to the recent research, personalized decision-making could enhance the clinical outcomes and patient-centered care [12].

 

Although global evidence on URS usage with distal stones of the ureter is in favor of the method, local data in resource-constrained areas are scarce. Efficacy and patient-centered outcomes must be assessed in order to influence practice in regional settings. This study aims to compare ESWL and URS in terms of stone-free rates and patient satisfaction for distal ureteric calculi.

MATERIALS AND METHODS:

Study design and setting: This comparative prospective study was conducted at Institute of Kidney diseases Hayatabad Peshawar for a period of six months from January 2025 to June 2025.

 

Study Population: Patients aged 18–65 years who presented with a single distal ureteric calculus measuring 5–15 mm, confirmed by non-contrast computed tomography (NCCT) or ultrasound, were included in the study. Patients with multiple ureteric stones, bilateral stones, and anatomical abnormalities of the urinary tract, pregnancy, coagulopathy, or active urinary tract infection were excluded.

 

Sample size calculation: A sample size calculation was performed to compare the stone-free rates between ureteroscopy (URS) and extracorporeal shockwave lithotripsy (ESWL). The WHO recommended formula for comparing two independent proportions was used [13]:

 

 

Where ​ ​represent the expected stone-free rates for URS and ESWL respectively. Using previously published rates of 90% for URS and 68% for ESWL [2], with a two-sided α = 0.05 and power (1−β) = 0.80, the minimum required sample size was calculated as 53 patients per group, yielding a total of 106 participants. The calculated value was rounded up to ensure adequate statistical power.

 

Patient Allocation and Grouping: The eligible patients were divided into two groups according to the treatment modality. Group A comprised of patients who received extracorporeal shockwave lithotripsy (ESWL) and Group B involved patients that received ureteroscopy (URS). The assignment to either category was done based on the patient choice and clinical appropriateness following the proper counseling on the advantages, risks, and nature of the procedures of the two treatments.

 

Procedure Protocols: Group A patients had ESWL in line with the EAU Guidelines on Urolithiasis and AUA Kidney Stone Guidelines [14] [15]. Surgery was done under a sedated or local anesthesia and shockwaves were administered at a frequency of 60 to 90impulses per minute. Fragments of stones were observed through the way of fluoroscopy or ultrasound. The patients were educated on hydration, analgesia and fragmental passage after the procedure. Imaging follow-up was done at 2 and 4 weeks to determine stone clearance. Group B patients received semi-rigid ureteroscopy with general or spinal anesthesia, according to the EAU and AUA procedures recommendations [14] [15]. A guide wire was placed to assist in the progression of the ureteroscope and the calculus was then directly viewed. Where necessary, stones were broken with a holmium laser lithotripsy or excised with retrieval equipment. Ureteral stents were put in where necessary and taken out 1-2 weeks later. At week 2 and week 4, imaging was used to confirm the status of the stones as being stone-free.

 

Outcome Measures: The stone-free rate (SFR) which was full clearance of the stone but without further intervention, measured by NCCT or ultrasound at 2-4 weeks after the procedure was the main outcome [14]. The procedure related complications, postoperative pain, and satisfaction among the patients were taken as secondary outcomes. The patient satisfaction was assessed based on a self-developed, 10-item questionnaire that dealt with procedures experience, perceived pain, comfort, and overall satisfaction. The score of each was on a 5-point Likert scale (1 = very dissatisfied, 5 = very satisfied) [16]. The questionnaire was also piloted on 10 patients to test its lucidity and practicability before data collection.

 

 

Data Analysis: SPSS version 25 was used in analyzing data. Continuous variables were given in terms of mean ± standard deviation and categorical variables were provided in form of frequencies and percentages. The Chi-square test was employed in the comparison of categorical variables, whereas the independent t-test was involved in the comparison of continuous variables. Multivariate logistic regression analysis was conducted to adapt all the possible confounding variables e.g. age, sex, stone size, and comorbidities on the primary, as well as, secondary outcomes. The p-value of < 0.05 was taken as statistically significant.

 

Ethical considerations: Before the study was commenced, the study received ethical approval in the Institutional Review Board of LRH. All the participants were given informed consent by clearly stating the aims of the study, the methods that would be used, the possible positive and negative impacts, and the risks.

RESULTS:

Baseline characteristics were comparable between the ESWL and URS groups as shown in Table 1, the ESWL group included 29 (54.7%) males and 24 (45.3%) females, while the URS group had 33 (62.3%) males and 20 (37.7%) females (χ²=0.37, p=0.54). Mean age was similar between ESWL (41.2 ± 12.1 years) and URS (42.4 ± 11.2 years) (t=0.56, p=0.58). Stone size (9.2 ± 2.4 mm vs. 9.5 ± 2.1 mm, t=0.70, p=0.48) and BMI (26.3 ± 3.1 vs. 25.9 ± 2.8, t=0.73, p=0.47) also showed no significant difference. Comorbidities, including diabetes (8 (15.1%) vs. 7 (13.2%), χ²=0.08, p=0.78) and hypertension (10 (18.9%) vs. 9 (17.0%), χ²=0.06, p=0.80), were similarly distributed. Prior renal stones were reported in 5 (9.4%) ESWL patients and 6 (11.3%) URS patients (χ²=0.10, p=0.75).

 

Table 1: Baseline Demographic and Clinical Characteristics of Patients (N = 106)

Variable

ESWL (n=53)

URS (n=53)

Test Used

Test Value

p-value

Age (years, mean ± SD)

41.2 ± 12.1

42.4 ± 11.2

Independent t-test

t = 0.56

0.58

Male gender, n (%)

29 (54.7%)

33 (62.3%)

Chi-square

χ² = 0.37

0.54

Female gender, n (%)

24 (45.3%)

20 (37.7%)

Chi-square

χ² = 0.37

0.54

Stone size (mm, mean ± SD)

9.2 ± 2.4

9.5 ± 2.1

Independent t-test

t = 0.70

0.48

BMI (kg/m², mean ± SD)

26.3 ± 3.1

25.9 ± 2.8

Independent t-test

t = 0.73

0.47

Diabetes mellitus, n (%)

8 (15.1%)

7 (13.2%)

Chi-square

χ² = 0.08

0.78

Hypertension, n (%)

10 (18.9%)

9 (17.0%)

Chi-square

χ² = 0.06

0.80

Previous renal stones, n (%)

5 (9.4%)

6 (11.3%)

Chi-square

χ² = 0.10

0.75

 

Legend: Independent t-test was used for continuous variables (t-values ranged from 0.56 to 0.73, all p > 0.47), and Chi-square test was used for categorical variables (χ²-values ranged from 0.06 to 0.37, all p > 0.54). No statistically significant differences were found between the groups.

 

As illustrated in Figure 1, the stone-free rate was significantly higher in the URS group, where 48 (90.6%) patients achieved stone clearance compared with 36 (67.9%) in the ESWL group. Conversely, residual stones were present in 17 (32.1%) ESWL patients and 5 (9.4%) URS patients at 2–4 weeks. The difference in stone-free rates between the two modalities was statistically significant, as confirmed by the Chi-square test (χ² = 8.52, p = 0.0035), indicating superior efficacy of URS over ESWL.

Figure 1: Primary Outcome: StoneFree Rate at 2–4 Weeks

 

Legend: The Chi-square test was used to compare the results of Stone-free in the groups. A high difference was found and URS reported high rates in stone-free rates compared to ESWL (χ² = 8.52, p = 0.0035).

 

Procedure-related complications were also more common in the ESWL group as shown in Figure 2, 15 (28.3) patients suffered complications in comparison to 7 (13.2) patients in URS group (χ² = 3.98, p = 0.046). Hematuria in 9 (17.0%) ESWL patients and 3 patients (5.7%) URS patients (χ²  = 3.23, p = 0.07, and χ²  = 1.37, p = 0.24) and dysuria in 5 (9.4) ESWL patients and 2 (3.8) URS patients (χ²  = 1.37, p = 0.24 and χ²  = 3.23, p = 0.07 The incidence of fever was rare 1 (1.9) in ESWL patient and 2 (3.8) in URS patient (χ² = 0.34, p = 0.56). The ESWL group did not show Ureteral mucosal injury, but URS patients had 2 (3.8) cases of the mucosal injury (χ² = 2.78, p = 0.15). Generally, ESWL showed more complication rates but most of the variations were not statistically significant except on the overall number of complication.

 

Figure 2: Procedure-Related Complications

 

Legend: All complications were compared between groups using Chi-square tests. A significant difference was found for total complications (χ² = 3.98, p = 0.046). Hematuria (χ² = 3.23, p = 0.07), dysuria (χ² = 1.37, p = 0.24), fever (χ² = 0.34, p = 0.56), and ureteral mucosal injury (χ² = 2.78, p = 0.15) showed no statistically significant differences.

 

Postoperative results, as presented in Table 2 indicated that the pain scores were much lower In the ESWL group, where the mean of the pain score was 4.9 ±  1.6, and on the URS group, the mean of the pain score was 5.8 ±  1.9. (t = 2.69, p = 0.008). Conversely, URS patients had more satisfaction with their patients, who reported that the mean score in the ESWL group was 4.3 ± 0.7 as compared to 3.6 ± 0.8 (t = 4.67, p < 0.001). These results suggest that despite the fact that ESWL was related to reduce postoperative pain, URS led to a much higher overall satisfaction.

 

Table 2: Postoperative Pain and Patient Satisfaction Scores

Parameter

ESWL (n=53)

URS (n=53)

Test Used

Test Statistic

p-value

Pain score (mean ± SD)

4.9 ± 1.6

5.8 ± 1.9

Independent t-test

t = 2.69

0.008

Satisfaction score (mean ± SD)

3.6 ± 0.8

4.3 ± 0.7

Independent t-test

t = 4.67

<0.001

Legend: Mean pain and satisfaction scores between ESWL and URS were compared using independent t-tests. Pain scores showed a significant difference (t = 2.69, p = 0.008), while satisfaction scores demonstrated a highly significant difference favoring URS (t = 4.67, p < 0.001).

 

As shown in Table 3, multivariate logistic regression identified ureteroscopy (URS) as the strongest predictor of achieving stone-free status, with an adjusted odds ratio of 4.21 (95% CI: 1.53–11.61; Wald = 7.77, p = 0.005). Stone size did not significantly influence stone clearance (OR = 0.91 per mm, 95% CI: 0.78–1.06; Wald = 1.43, p = 0.23). Similarly, age (OR = 0.99, p = 0.72), male sex (OR = 1.12, p = 0.77), and the presence of comorbidities (OR = 0.88, p = 0.78) were not significant predictors. These results support the idea that URS alone offers better clearance rates irrespective of demographics and stone properties.

 

Table 3: Multivariate Logistic Regression for Predictors of Stone-Free Status

Variable

Adjusted OR

95% CI

Wald Statistic

p-value

URS vs. ESWL

4.21

1.53–11.61

Wald = 7.77

0.005

Stone size (per mm)

0.91

0.78–1.06

Wald = 1.43

0.23

Age (per year)

0.99

0.96–1.03

Wald = 0.13

0.72

Male sex

1.12

0.51–2.47

Wald = 0.08

0.77

Comorbidity (any)

0.88

0.37–2.11

Wald = 0.08

0.78

 

Legend: Multivariate logistic regression was performed using the Wald test to assess predictors of stone-free status. URS was a significant independent predictor of stone clearance (Wald = 7.77, p = 0.005). Stone size (Wald = 1.43, p = 0.23), age (Wald = 0.13, p = 0.72), male sex (Wald = 0.08, p = 0.77), and comorbidity status (Wald = 0.08, p = 0.78) showed no statistically significant associations.

DISCUSSION:

The findings of this study demonstrated that ureteroscopy (URS) was far much better than extracorporeal shockwave lithotripsy (ESWL) in the treatment of distal ureteric calculi. Despite the increased postoperative pain being linked with URS, there was more patient satisfaction, reduced complications, and overall improved treatment outcomes. ESWL though a less invasive method demonstrated a reduced clearance rate with a higher risk of need of adjunctive interventions. The multivariate analysis also proved that URS is the most significant independent predictor of successful stone clearance despite the comorbidities like age, sex, stone size, and comorbidities.

 

The superior stone-free rate obtained with URS in the study is consistent with international data of always good high clearance rates of distal ureteric stones, generally more than 85-90% [17]. The literature on ESWL has a range of outcomes between 60-75% which is agreeable with the 67.9% clearance in this case [18]. The trends of complications were also in line with the existing data with URS reporting fewer yet marginally more invasive complications, whereas ESWL reported a higher rate of mild and self-limiting complications like hematuria and dysuria [19]. This was anticipated to result in pain that was greater following URS because of manipulation and stent insertion in the ureters, and ESWL generated moderate but less severe pain [20]. Nevertheless, the level of patient satisfaction was still higher in URS, as the value of effective and immediate stone clearance is higher [21]. In general, the results of the study closely reflect the findings on the topic in the world that URS is more reliable as a modality, and ESWL is the less invasive option but less predictable [22].

 

Limitations and Future Recommendations: There are also certain limitations in this study such as the design of the study that is single center and that patients were not randomly allocated, thereby exposing them to selection bias. Late complications or recurrences could have eluded the short follow-up period. The self-constructed satisfaction survey could be a limiting factor in comparing results with other studies and the use of ultrasound in some follow up scans could over look residual fragments of stones. Further studies ought to incorporate multicentered randomized studies on a larger scale to enhance external validity. The follow-up should be longer to evaluate the recurrence and the long-term outcomes. Patient satisfaction standard and validated instruments are to be involved and additional analysis according to stone density, composition, and anatomical differences is suggested to promote the better customization of treatment

CONCLUSION:

This study demonstrated that ureteroscopy has much higher rates of stone-free rates, low rates of complications and patient satisfaction than extra-corporal shockwave lithotripsy as a therapeutic option in the treatment of distal ureteric calculi. Despite the fact that URS was linked to greater postoperative pain, its better efficacy and reliability makes it the more effective form of treatment in general. ESWL is also an option that has an inferior and less predictable clearance but is a useful, non-invasive option. These results promote personalized choice of courses of treatment depending on the priorities of the patient, clinical assessment, and the availability of resources.

REFERENCES:

1.                Lv G, Qi W, Gao H, Zhou Y, Zhong M, Wang K, Liu Y, Zhang Q, Zhou C, Li Y, Zhang L. Safety and efficacy of extracorporeal shock wave lithotripsy vs. flexible ureteroscopy in the treatment of urinary calculi: a systematic review and meta-analysis. Frontiers in Surgery. 2022 Nov 7;9:925481.doi.org/10.3389/fsurg.2022.925481

2.                Fankhauser CD, Weber D, Müntener M, Poyet C, Sulser T, Hermanns T. Effectiveness of flexible ureterorenoscopy versus extracorporeal shock wave lithotripsy for renal calculi of 5–15 mm: results of a randomized controlled trial. European Urology Open Science. 2021 Mar 1;25:5-10.doi.org/10.1016/j.euros.2021.01.001

3.                Hedda DS. Comparative Efficacy of Shockwave Lithotripsy and Ureteroscopy in Treating Renal and Ureteral Stones. Journal of Contemporary Clinical Practice. 2025 Apr 8;11:103-8.DOI : 10.61336/jccp/25-04-19

4.                Bowen DK, Song L, Faerber J, Kim J, Scales Jr CD, Tasian GE. Re-treatment after ureteroscopy and shock wave lithotripsy: a population based comparative effectiveness study. The Journal of urology. 2020 Jun;203(6):1156-62.doi.org/10.1097/JU.0000000000000712

5.                Dasgupta R, Cameron S, Aucott L, MacLennan G, Thomas RE, Kilonzo MM, Lam TB, N’Dow J, Norrie J, Anson K, Burgess N. Shockwave lithotripsy versus ureteroscopic treatment as therapeutic interventions for stones of the ureter (TISU): a multicentre randomised controlled non-inferiority trial. European urology. 2021 Jul 1;80(1):46-54.doi.org/10.1016/j.eururo.2021.02.044

6.                Jung HD, Hong Y, Lee JY, Lee SH. A systematic review on comparative analyses between ureteroscopic lithotripsy and shock-wave lithotripsy for ureter stone according to stone size. Medicina. 2021 Dec 16;57(12):1369.doi.org/10.3390/medicina57121369

7.                Tikar DC, Bidarahalli DA, Mahoorkar DD. Comparison Between Extracorporeal Shock Wave Lithotripsy and Ureteroscopic Stone Extraction in the Treatment of Ureteral Stones: An Observational Study. Res. J. Med. Sci. 2024 Dec 30;18:667-72.doi: 10.36478/makrjms.2024.12.667.672

8.                Bağcı U, Dinçkal M, Tekin A, Kızılay F, Nazlı O, Ulman İ. Comparing the efficacy of extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy in the treatment of proximal ureteral stones in children: A retrospective study. International Journal of Urology. 2023 Nov;30(11):985-90.doi.org/10.1111/iju.15245

9.                Sindhi Y, Hashmi AH, Usman G, Zaman A, Hussain M, Qamar U. Extracorporeal shockwave lithotripsy versus ureteroscopy: a first line distal ureteric stone treatment. Pakistan Journal of Medicine and Dentistry. 2021;10(2):49-54.doi.org/10.36283/PJMD10-2/009

10.             Harahap FH, Liwanto GE, Rumahorbo PF, Nathan DS, Halim AP. The outcomes of extracorporeal shock wave compared to ureteroscopic lithotripsy for the treatment of ureteral stones: A Comprehensive Systematic Review. The Medical Journal of Urology and General Surgery. 2024 Oct 7;1(1):1-5.https://medicaljournalinternational.org/tmjugs/article/view/56

11.             Schulz C, Becker B, Netsch C, Herrmann TR, Gross AJ, Westphal J, Knoll T, König HH. Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany. World Journal of Urology. 2022 Mar;40(3):781-8.doi.org/10.1007/s00345-021-03903-2

12.             Bahçeci T, Kızılay F, Çal AÇ, Şimşir A. Comparison of shockwave lithotripsy and laser ureterolithotripsy for ureteral stones. Journal of Urological Surgery. 2021 Sep 10.doi.org/10.4274/jus.galenos.2021.2021.0006

13.             Lwanga SK, Lemeshow S. Sample size determination in health studies. Geneva: World Health Organization. 1991 Sep 20;1. https://lib.umku.ac.id/wp-content/uploads/2022/06/Sample-size-determination-in-health-studies-a-practical-manual.pdf

14.             Skolarikos A, Jung H, Neisius A, Petřík A, Somani B, Tailly T, et al. EAU Guidelines on Urolithiasis. European Association of Urology; 2023. Available from: https://uroweb.org/guidelines/urolithiasis

15.             American Urological Association. Kidney Stones: Surgical Management Guideline. 2021. https://www.auanet.org/guidelines-and-quality/guidelines/kidney-stones-surgical-management-guideline

16.             Likert R. A Technique for the Measurement of Attitudes [Internet]. Archives of Psychology No. 140. New York: The Science Press; 1932. Available from: https://legacy.voteview.com/pdf/Likert_1932.pdf

17.             Ahmad N, Khan K, Amjad S, Rasheed A, Iftikhar U. Extracorporeal Shock Wave Lithotripsy versus Ureteroscopy Lithoclast in Management of Upper Ureteric Stones. InMedical Forum Monthly 2022 (Vol. 33, No. 3).http://medicalforummonthly.com/index.php/mfm/article/view/584

18.             Yao F, Jiang X, Xie B, Liu N. Comparison of ureteroscopy (URS) complementary treatment after extracorporeal shock wave lithotripsy failure with primary URS lithotripsy with holmium laser treatment for proximal ureteral stones larger than10mm. BMC urology. 2021 Sep 13;21(1):126.doi.org/10.1186/s12894-021-00892-7

19.             Mustafa G, Mahar NA, Qureshi HH, Mustafa M, Fayaz M, Hassan AS. Comparison of Outcomes of Extracorporeal Shockwave Lithotripsy with Ureteroscopic Lasertripsy for Management of Proximal Ureteral Stones. Age (years). 2024 Jan 1;39(14.06):41-0.doi: 10.29271/jcpsp.2024.01.101

20.             Adnan M, Fazal-ur-Rehman Khan RA. Comparison of Treatment Efficacy of Extracorporeal Shock Wave Lithotripsy and Pneumatic Ureteroscopic Lithotripsy for Lower Ureteric Stones. InMedical Forum Monthly 2021 (Vol. 32, No. 5).http://medicalforummonthly.com/index.php/mfm/article/view/1726

21.             Cao L, Wang YQ, Yu T, Sun Y, He J, Zhong Y, Li X, Sun X. The effectiveness and safety of extracorporeal shock wave lithotripsy for the management of kidney stones: A protocol of systematic review and meta-analysis. Medicine. 2020 Sep 18;99(38):e21910.DOI: 10.1097/MD.0000000000021910

22.             Petrides N, Ismail S, Anjum F, Sriprasad S. How to maximize the efficacy of shockwave lithotripsy. Turkish journal of urology. 2020 Oct 30;46(Suppl 1):S19.doi.org/10.5152/tud.2020.20441